# Division of Information Disclosure Policy

Source: https://www.keypedia.com/offices/division-of-information-disclosure-policy/0c0ebf49-2470-4002-937b-bb098361ac5f
Abbreviation: DIDP
Location: Silver Spring, Maryland, USA

---

## Details

- Postal Code: 20993
- Thoroughfare: 10903 New Hampshire Avenue
- Premise: WO66-5521
- Office URL: https://www.fda.gov/drugs/cder-conversations/disclosing-information-about-drugs-and-fostering-cders-transparency-efforts
- Created At: 2024-09-13T03:04:10+00:00

## Records at this office

- [Hetero Labs Limited (Warehouse)](https://www.keypedia.com/records/483/hetero-labs-limited-warehouse/776ae0eb-99b2-456d-b662-2f2acf296045) — date: September 26, 2025
- [Linde Gas & Equipment Inc.](https://www.keypedia.com/records/483/linde-gas-equipment-inc/4956ee03-5a95-4bcd-b9c5-25efad7a5d50) — date: July 25, 2025
- [Siegfried El Masnou, S.A.](https://www.keypedia.com/records/483/siegfried-el-masnou-sa/ef38a174-b92d-4b4c-9ab6-7d5c8c0edec3) — date: July 11, 2025
- [Glenmark Pharmaceuticals Inc USA](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-inc-usa/facf78be-e9f5-44d2-ad1f-a2fccd330cdc) — date: June 16, 2025
- [TECHNICHEM CORP](https://www.keypedia.com/records/483/technichem-corp/743e6932-0b09-4809-bf8a-5bd0c7d02de1) — date: April 28, 2025
- [Sri Krishna Pharmaceuticals Limited Unit I](https://www.keypedia.com/records/483/sri-krishna-pharmaceuticals-limited-unit-i/3a5ac51e-f6e9-4299-a0e6-d218b226bcab) — date: April 18, 2025
- [NeuroSync, Inc.](https://www.keypedia.com/records/483/neurosync-inc/06165682-d9fa-4727-be45-c0ba12654995) — date: February 5, 2025
- [Fresenius Medical Care Holdings, Inc.](https://www.keypedia.com/records/483/fresenius-medical-care-holdings-inc/c9f1466d-e7fd-4aa6-945b-0608ce63b008) — date: September 16, 2024
- [Vital Rx, Inc. dba Atlantic Pharmacy and Compounding](https://www.keypedia.com/records/483/vital-rx-inc-dba-atlantic-pharmacy-and-compounding/04a0a290-fcac-4432-86f8-7b220082d775) — date: August 10, 2017
- [Bella Pharmaceuticals, Inc.](https://www.keypedia.com/records/483/bella-pharmaceuticals-inc/82ae1492-168e-4ec5-bf94-d09204721919) — date: August 3, 2017

## Related Offices

- [Office of Compliance Intervention and Consultation](https://www.keypedia.com/offices/office-of-compliance-intervention-and-consultation/0b3cfe41-f423-41e0-b1a1-caab23b32d54)
- [Acting Division Director](https://www.keypedia.com/offices/acting-division-director/94758cee-45fe-4207-8c63-497d74b732b6)
- [Bureau of Environmental Health](https://www.keypedia.com/offices/bureau-of-environmental-health/87a06a18-caf6-42b9-8dd5-f53ec7a64384)
- [Division of Nonprescription Drug Products](https://www.keypedia.com/offices/division-of-nonprescription-drug-products/f89a77f0-4378-476b-b846-97563e1b959d)
- [Division of Reproductive and Urologic Products](https://www.keypedia.com/offices/division-of-reproductive-and-urologic-products/29137540-95d5-48bc-a13a-501ed2bf9c3f)

## Officers

- [Special Projects Team Lead](https://www.keypedia.com/people/jason-schilling/ff613660-d7fa-4025-9840-c837841dec75)